Titlebook: Clinical Molecular Diagnostics; Shiyang Pan,Jinhai Tang Book 2021 People‘s Medical Publishing House Co. Ltd. 2021 clinical validation.dise

只看該作者 · 發(fā)表于 2025-3-25 05:47:39

https://doi.org/10.1057/9780230376373ropriate procedures. If not applicable, it must be re-established. Therefore, the establishment of a reliable biological reference interval for upcoming and ongoing testing projects is one of the essential tasks that need to be accomplished in pre-clinical and clinical applications.

只看該作者 · 發(fā)表于 2025-3-25 08:16:23

只看該作者 · 發(fā)表于 2025-3-25 14:30:19

只看該作者 · 發(fā)表于 2025-3-25 18:46:20

只看該作者 · 發(fā)表于 2025-3-25 21:39:27

https://doi.org/10.1057/9780230376373ion reagents are gradually entering the market, and the scale is expanding. To ensure the quality of individualized diagnostic reagents and assure the effectiveness of the detection system, we need to verify the detection performance of these systems.

只看該作者 · 發(fā)表于 2025-3-26 01:17:11

只看該作者 · 發(fā)表于 2025-3-26 06:31:39

B. Steinke,H. Treugut,P. Ostendorf Therefore, there are countless links between the immune system and molecular biomarkers, and molecular biomarkers have important clinical significance for the prevention, diagnosis, and treatment of immune system diseases.

只看該作者 · 發(fā)表于 2025-3-26 10:58:17

只看該作者 · 發(fā)表于 2025-3-26 13:20:20

只看該作者 · 發(fā)表于 2025-3-26 18:03:22

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛(ài)論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-28 07:18
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved